A

Annexon Biosciences

85 employees

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neurodegeneration
Life Science
Therapeutics
Ophthalmology
Health Diagnostics
Health Care
Autoimmune

Date founded

2011

Funding rounds raised

Total raised

$130M

from 14 investors over 14 rounds

A

Annexon Biosciences raised $130M on July 8, 2022

Investors: Adage Capital Management, Driehaus Capital Management LLC and Redmile Group

A

Annexon Biosciences raised $100M on July 1, 2020

Investors: Farallon Capital Management, Logos Global Management, LP, Redmile Group, Eventide Asset Management and Surveyor Capital

A

Annexon Biosciences raised $75M on December 19, 2018

Investors: Adage Capital Management, Blackstone Technology Group and Surveyor Capital

A

Annexon Biosciences raised $44M on June 23, 2016

Investors: Clarus Ventures, LLC and Correlation Ventures

A

Annexon Biosciences raised $34M on December 15, 2014

Investors: Clarus Ventures, LLC

FAQ